Effects of heparin and lisofylline on pulmonary function after smoke inhalation injury in an ovine model.

OBJECTIVE This study evaluates the effects of heparin alone and in combination with lisofylline, 1-(5-R-hydroxyhexyl)3,7-dimethylxanthine, on severe smoke injury. DESIGN Prospective animal study with concurrent controls. SETTING An animal laboratory. SUBJECTS Eighteen 1-yr-old female sheep, weighing 24-32 kg. INTERVENTIONS After smoke exposure and tracheostomy, animals were divided into three groups. Group S (n = 6) received nebulized saline through an endotracheal tube every 4 hrs for 48 hrs. Group H (n = 6) received 10,000 units of nebulized heparin every 4 hrs. Group LH (n = 6) was treated with nebulized heparin and intravenous infusion of lisofylline (10 mg x kg(-1) x hr(-1)) for 48 hrs after a bolus injection (20 mg/kg). Animals initially breathed room air spontaneously. If PaO2 was <50 torr and PaCO2 >60 torr, animals were mechanically ventilated. Sheep were killed 48 hrs postinjury. MEASUREMENTS AND MAIN RESULTS Blood gases were measured serially. At 48 hrs, ventilation perfusion distribution mismatching was analyzed by using the multiple inert gas elimination technique. Lung malondialdehyde was determined. The postinjury increase in alveolar-arterial oxygen tension gradient (LH, 36.7 +/- 3.5 vs. S, 89.0 +/- 24.6 torr at 48 hrs) was significantly attenuated in those animals receiving LH. The percentage of pulmonary shunt, Qs/Qt (LH, 20.8 +/- 4.9 vs. S, 36.6 +/- 4.6%), and the percentage of animals that required ventilation (LH, 0 vs. S, 67%) were significantly reduced in LH. Multiple inert gas elimination technique study showed that the true shunt fraction was decreased in LH. Lung malondialdehyde was significantly less in LH (LH, 0.33 +/- 0.06 vs. S, 0.56 +/- 0.09 nmol/mg protein). There was no significant difference in any of these variables between H and S. CONCLUSION Treatment with heparin alone did not attenuate pulmonary dysfunction after severe smoke injury. Combined treatment with nebulized heparin and systemic lisofylline had beneficial effects on pulmonary function in association with a decrease in blood flow to poorly ventilated areas and less lipid peroxidation.

[1]  M. Fink,et al.  Lisofylline ameliorates intestinal mucosal barrier dysfunction caused by ischemia and ischemia/reperfusion. , 1999, Shock.

[2]  田崎 修.  Effect of Sulfo Lewis C on smoke inhalation injury in an ovine model , 1998 .

[3]  S. Sriram,et al.  Prevention of experimental allergic encephalomyelitis via inhibition of IL-12 signaling and IL-1-mediated Th1 differentiation; an effect of the novel anti-inflammatory drug lisofylline , 1998, Journal of Neuroimmunology.

[4]  A. Mason,et al.  Effect of Sulfo Lewis C on smoke inhalation injury in an ovine model. , 1998, Critical care medicine.

[5]  G. Rice,et al.  Modulating phosphatidic acid metabolism decreases oxidative injury in rat lungs. , 1997, The American journal of physiology.

[6]  W. Cioffi,et al.  Effects of burns on inhalation injury. , 1997, The Journal of trauma.

[7]  G. Berry,et al.  The effects of post-treatment with lisofylline, a phosphatidic acid generation inhibitor, on sepsis-induced acute lung injury in pigs. , 1997, American journal of respiratory and critical care medicine.

[8]  J. Repine,et al.  Lisofylline prevents leak, but not neutrophil accumulation, in lungs of rats given IL-1 intratracheally. , 1997, Journal of applied physiology.

[9]  J. Slattery,et al.  Metabolism of lisofylline and pentoxifylline in human liver microsomes and cytosol. , 1996, Drug metabolism and disposition: the biological fate of chemicals.

[10]  G. Rice,et al.  Lisofylline decreases white cell adhesiveness and improves survival after experimental hemorrhagic shock. , 1996, Critical care medicine.

[11]  D. Grant,et al.  The antioxidant activity of heparins. , 1996, Biochemical Society transactions.

[12]  G. De Luca,et al.  Heparin protection against Fe2+‐and Cu2+‐mediated oxidation of liposomes , 1996, FEBS letters.

[13]  G. Palladini,et al.  The effect of heparin on Cu2+‐mediated oxidation of human low‐density lipoproteins , 1995 .

[14]  H. F. Goode,et al.  The Effect of Anticoagulant Choice on Apparent Total Antioxidant Capacity using Three Different Methods , 1995, Annals of clinical biochemistry.

[15]  D. Herndon,et al.  Effects of manganese superoxide dismutase on lung fluid balance after smoke inhalation. , 1995, Journal of applied physiology.

[16]  R. Shenkar,et al.  Phosphatidic acid signaling mediates lung cytokine expression and lung inflammatory injury after hemorrhage in mice , 1995, The Journal of experimental medicine.

[17]  Y. Youn,et al.  Effect of graded increases in smoke inhalation injury on the early systemic response to a body burn. , 1995, Critical care medicine.

[18]  G. Palladini,et al.  The effect of heparin on Cu(2+)-mediated oxidation of human low-density lipoproteins. , 1995, FEBS letters.

[19]  G. Rice,et al.  CT‐1501R SELECTIVELY INHIBITS INDUCED INFLAMMATORY MONOKINES IN HUMAN WHOLE BLOOD EX VIVO , 1994, Shock.

[20]  A. Mason,et al.  The effects of pentoxifylline on pulmonary function following smoke inhalation. , 1994, The Journal of surgical research.

[21]  T. Kensler,et al.  Myeloperoxidase as a biomarker of skin irritation and inflammation. , 1994, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.

[22]  Cioffi,et al.  The effect of inhaled nitric oxide on smoke inhalation injury in an ovine model. , 1993, The Journal of trauma.

[23]  R. Demling,et al.  Lung and systemic oxidant and antioxidant activity after graded smoke exposure in the rat. , 1994, Circulatory shock.

[24]  L. Brink,et al.  DROWNING AND NEAR-DROWNING , 2001 .

[25]  Yorihiro Yamamoto,et al.  Lipid Peroxides as the Initiating Factor of Atherosclerosis , 1993, Annals of the New York Academy of Sciences.

[26]  J. Zwischenberger,et al.  Heparin improves oxygenation and minimizes barotrauma after severe smoke inhalation in an ovine model. , 1993, Surgery, gynecology & obstetrics.

[27]  D. Herndon,et al.  Administration of a synthetic antiprotease reduces smoke-induced lung injury. , 1990, Journal of applied physiology.

[28]  J. G. Chen,et al.  Transport critical current density and microstructure in extruded YBa2Cu3O7−x wires processed by zone melting , 1990 .

[29]  R. Rodríguez-Roisín,et al.  Clinical relevance of ventilation-perfusion inequality determined by inert gas elimination. , 1990, The European respiratory journal.

[30]  P. Talke,et al.  Effects of allopurinol on smoke inhalation in the ovine model. , 1990, Journal of applied physiology.

[31]  D. Herndon,et al.  The pathophysiology of inhalation injury--a review. , 1988, Burns, including thermal injury.

[32]  D. Herndon,et al.  The effect of leukocyte depletion on smoke inhalation injury in sheep. , 1988, Surgery.

[33]  D. Herndon,et al.  Treatment of smoke-induced pulmonary injury with nebulized dimethylsulfoxide. , 1988, Circulatory shock.

[34]  D. Herndon,et al.  Dimethylsulfoxide with heparin in the treatment of smoke inhalation injury. , 1988, The Journal of burn care & rehabilitation.

[35]  A. Mason,et al.  A dose-responsive model of smoke inhalation injury. Severity-related alteration in cardiopulmonary function. , 1987, Annals of surgery.

[36]  J. Saffle,et al.  Effect of inhalation injury on fluid resuscitation requirements after thermal injury. , 1986, American journal of surgery.

[37]  D. Herndon,et al.  Pulmonary injury in burned patients. , 1985, Critical care clinics.